Northern Trust Corp Grows Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Northern Trust Corp boosted its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 2.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 93,789 shares of the medical instruments supplier’s stock after purchasing an additional 1,825 shares during the quarter. Northern Trust Corp owned about 1.73% of Mesa Laboratories worth $12,368,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Pacer Advisors Inc. raised its position in Mesa Laboratories by 4.3% during the 4th quarter. Pacer Advisors Inc. now owns 1,755 shares of the medical instruments supplier’s stock worth $231,000 after buying an additional 73 shares during the last quarter. Berry Wealth Group LP raised its position in Mesa Laboratories by 5.3% during the 4th quarter. Berry Wealth Group LP now owns 1,657 shares of the medical instruments supplier’s stock worth $219,000 after buying an additional 83 shares during the last quarter. Los Angeles Capital Management LLC raised its position in Mesa Laboratories by 3.0% during the 4th quarter. Los Angeles Capital Management LLC now owns 3,394 shares of the medical instruments supplier’s stock worth $448,000 after buying an additional 100 shares during the last quarter. Alliancebernstein L.P. raised its position in Mesa Laboratories by 2.6% during the 4th quarter. Alliancebernstein L.P. now owns 5,584 shares of the medical instruments supplier’s stock worth $736,000 after buying an additional 141 shares during the last quarter. Finally, Amundi raised its position in Mesa Laboratories by 81.6% during the 4th quarter. Amundi now owns 661 shares of the medical instruments supplier’s stock worth $91,000 after buying an additional 297 shares during the last quarter. Hedge funds and other institutional investors own 90.60% of the company’s stock.

Mesa Laboratories Stock Up 0.9%

Shares of Mesa Laboratories stock opened at $122.42 on Friday. The company has a market cap of $665.23 million, a P/E ratio of -2.65 and a beta of 0.97. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.53 and a current ratio of 0.71. Mesa Laboratories, Inc. has a one year low of $83.68 and a one year high of $155.12. The firm has a fifty day moving average of $118.33 and a two-hundred day moving average of $126.66.

Mesa Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Friday, May 30th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, May 30th. This represents a $0.64 dividend on an annualized basis and a yield of 0.52%. Mesa Laboratories’s payout ratio is currently -1.38%.

Insiders Place Their Bets

In other news, CEO Gary M. Owens sold 21,000 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $123.91, for a total value of $2,602,110.00. Following the completion of the transaction, the chief executive officer now owns 43,337 shares in the company, valued at $5,369,887.67. This trade represents a 32.64% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 4.40% of the stock is owned by insiders.

About Mesa Laboratories

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.